BioNxt Solutions Inc. (BNXT) | Finanzwire

Basculer en Français

8301	Companies
115073	Keywords
55420	Articles
62512	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 03/13/2024 at 08:10, 8 months 8 days ago

BioNxt Reports Promising Results in ODF Cladribine Study for MS

BioNxt Solutions Inc. Multiple Sclerosis Cladribine Pharmacokinetic Study Drug Delivery Technology
PRESS RELEASE

published on 03/13/2024 at 08:05, 8 months 8 days ago

BioNxt Reports Successful Results From ODF Cladribine PK Study
BioNxt Solutions Inc. announces successful completion of comparative pharmacokinetic study for its oral dissolvable film Cladribine product for Multiple Sclerosis treatment, demonstrating rapid absorption similar to reference drug

BioNxt Solutions Inc. Multiple Sclerosis Cladribine Pharmacokinetic Study Drug Delivery System
PRESS RELEASE

published on 02/17/2024 at 01:50, 9 months 4 days ago

BioNxt Solutions Finalizes Agreement
BioNxt Solutions Inc. finalizes Settlement Agreement with a creditor to settle $282,415 debt through issuance of common shares and a cash payment. Debt to be settled in three instalments of shares based on market price

Common Shares Debt Settlement BioNxt Solutions Inc. Settlement Agreement Creditor
PRESS RELEASE

published on 01/30/2024 at 05:48, 9 months 22 days ago

BIONXT SOLUTIONS ANNOUNCES CLOSING OF FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT
BioNxt Solutions Inc. closes final tranche of non-brokered private placement, raising gross proceeds of $288,000 to fund drug development and working capital purposes

Private Placement Working Capital Investment Drug Development BioNxt Solutions Inc.
PRESS RELEASE

published on 12/22/2023 at 09:05, 10 months 30 days ago

BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
PRESS RELEASE

published on 12/22/2023 at 01:50, 10 months 30 days ago

BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
PRESS RELEASE

published on 12/12/2023 at 09:05, 11 months 9 days ago

BioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery Products
PRESS RELEASE

published on 12/09/2023 at 04:30, 11 months 12 days ago

BioNxt Solutions Announces Completion of Debenture and Interest Settlement and Issuance of Finder’s Warrants
PRESS RELEASE

published on 11/25/2023 at 01:44, 11 months 26 days ago

Bionxt Solutions Announces Convertible Debenture and Interest Settlement
PRESS RELEASE

published on 11/20/2023 at 09:05, 1 year ago

BioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis Treament

Accesswire

Published on 11/21/2024 at 17:35, 59 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 1 hour 4 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 2 hours 4 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 33 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 34 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 17:58, 35 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 42 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 42 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 16:00, 2 hours 34 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 2 hours 52 minutes ago

Edison issues report on Murray Income Trust (MUT)

Les Echos

Published on 11/21/2024 at 06:58, 11 hours 36 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 23 hours 14 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE